Time to Benefit After Intensive Blood Pressure Reduction in Older Adults
Patients’ life expectancy should be considered when deciding whether to intensify hypertension treatment, according to investigators.
Patients’ life expectancy should be considered when deciding whether to intensify hypertension treatment, according to investigators.
Significant but weaker associations with selected adverse outcomes seen for preexisting hypertension, diabetes, and ischemic heart disease
Highest risk for diabetes seen for those with hypertension, AS compared with those with normotension and normal AS
Established CVD risk factors account for 57 and 84% of the increased rate of CVD for preeclampsia, gestational hypertension
Pulmonary hypertension is common among patients with chronic kidney disease or end-stage kidney disease.
Study findings suggest the nephroprotective effects of both drug classes are complementary.
New study is the first to examine the effect of the use of renin-angiotensin-aldosterone system inhibitors on AKI in COVID-19.
Even at low concentrations, uranium, a radioactive metal, is an important risk factor for chronic diseases
Those with accelerated versus stable cardiovascular risk trajectory have increased risk for memory decline
Each standard deviation increase in BP polygenic risk score linked to 12% increased hazard of adverse CV events